Single-use Bioprocessing Probes & Sensors Market Growth & Trends

The global single-use bioprocessing probes and sensors market size is expected to reach USD 4.8 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.2% from 2020 to 2027. The bioprocessing industry has witnessed a significant increase in the adoption of single-use systems, especially by biologic manufacturers over the past few years. Increasing implementation of disposables technologies, commercial advantages offered by disposable products, availability of improved bioprocess, and easy monitoring process for bioprocessing have boosted revenue growth for the market.

Large players as well as small to medium-sized players in the biopharmaceutical space are switching to the implementation of disposable bioprocessing equipment to meet the rising pressure on drug developers to cater to the consumer’s therapeutics demand. This is anticipated to increase the demand for suitable, better quality, and compatible products offered in this space for biopharmaceutical manufacturing, thus further propelling the revenue growth.

Expanding usage of disposable systems has resulted in lucrative growth for operating players. Key players are making focused efforts to boost their business presence. OEMs are collaborating with independent single-use suppliers to fill the technological gap. Some key OEMs are integrating disposable sensors in their equipment used for various applications, thereby accelerating the adoption of products in this space. The key players are engaged in collaboration with therapy developers to support their product development process.

Single-use Bioprocessing Probes & Sensors Market Report Highlights

  • In terms of sensor type, single-use pH and dissolved oxygen sensors are the most used disposable sensors in the bioprocessing industry. Products for pressure measurement have already become widely accepted and adopted
  • By workflow, the application of disposable bioreactors is increasing in upstream biopharmaceutical production, which has also driven the products’ usage in this segment. Single-use dissolved oxygen and pH sensors are increasingly used in upstream applications leading to the large revenue share of this segment
  • Based on end use, biopharmaceutical manufacturers have emerged as the key end user of the market. Increasing adoption of single-use technologies by CMOs is one of the key factors fueling the growth of biopharmaceutical manufacturers
  • North America dominated the global market in 2019 owing to the presence of biopharmaceutical clusters and proactiveness of operating end users in adopting new technologies
  • Asia Pacific is expected to be the fastest-growing regional market over the forecast period owing to the expanding biomanufacturing capabilities in Asian countries